Screener
Nkarta, Inc.
NKTXNkarta is a clinical-stage biopharmaceutical company developing allogeneic, off-the-shelf natural killer (NK) cell therapies.
$188.37M+18.4%
Earnings
Next report
Nov 10, 2026 (in 2 months)EPS estimate-$0.40
Competitors
By market cap
Profile
Nkarta is a clinical-stage biopharmaceutical company developing allogeneic, off-the-shelf natural killer (NK) cell therapies. The company leverages a proprietary modular engineering platform to create CAR NK cells designed to be more accessible and better tolerated than traditional autologous T-cell therapies. Its primary focus is on treating B-cell mediated autoimmune diseases by targeting the CD19 antigen to deplete pathogenic B cells.
Competitive position
Nkarta is a pioneer in allogeneic CAR NK therapies, utilizing a proprietary platform that includes mbIL-15 for cell persistence and internal cGMP manufacturing to ensure scalability.
GeographiesUnited States
Customer segmentsSpecialized Treatment Centers, Hospitals, Outpatient Clinics
Business modelBiopharmaceutical Research and Development
SuppliersHealthy Human Donors (Leukapheresis), Contract Manufacturing Organizations (for NKSTIM cells and retrovirus), Specialized Lab Equipment Providers, Raw Material Suppliers for Cell Culture
CustomersSpecialized Medical Centers, Academic Research Institutions, Pharmaceutical Distributors
CountryUnited States of America
Listed2020
Employees150.0
CEOPaul J. Hastings
SectorHealthcare
IndustryBiotechnology
Websitenkartatx.com
FilingsSEC EDGAR
FAQ
- What is Nkarta, Inc.'s market cap?
- Nkarta, Inc. (NKTX) has a market capitalization of $188.4M and trades on NASDAQ.
- Who are Nkarta, Inc.'s competitors?
- Nkarta, Inc.'s key competitors include Kyverna Therapeutics, Cabaletta Bio, Fate Therapeutics, and others. These companies compete in similar markets and product categories.
- Who does Nkarta, Inc. partner with?
- Nkarta, Inc.'s notable partners include National University of Singapore, St. Jude Children’s Research Hospital, Inc., Columbia University Irving Medical Center, and others.
- Where is Nkarta, Inc. headquartered?
- Nkarta, Inc. is headquartered in United States of America and employs approximately 150 people. It has been publicly traded since 2020.